2078 Results

People

  1. Brennan
    Brennan
  2. Fong
    Fong
  3. Shah
    Shah
  4. Rusch
    Rusch
  5. Jarnagin
    Jarnagin
  6. Blumgart
    Blumgart
  7. Gonen
    Gonen
  8. Herr
    Herr
  9. Shaha
    Shaha
  10. Barakat
    Barakat

Groups

  1. Surgery (931)
  2. Department of Medicine (716)
  3. Solid Tumor Oncology Division (466)
  4. Survivorship Research (456)
  5. Sloan Kettering Institute Faculty (296)
  6. Epidemiology and Biostatistics (282)
  7. Biostatistics Service (248)
  8. Molecular Pharmacology and Chemistry Program Faculty (237)
  9. Center for Pancreatic Cancer Research (236)
  10. Center for Hematologic Malignancies (232)
  1. "survival rate"
Formats
  1. Journal Article (1972)
  2. Conference Paper (47)
  3. Review (22)
  4. Editorial (14)
  5. Meeting Abstract (8)
  6. Research Letter (8)
  7. Correspondence (6)
  8. Guidelines (1)
Groups
  1. Surgery (931)
  2. Department of Medicine (716)
  3. Solid Tumor Oncology Division (466)
  4. Survivorship Research (456)
  5. Sloan Kettering Institute Faculty (296)
  6. Epidemiology and Biostatistics (282)

More Groups

People
  1. Murray Brennan (153)
  2. Yuman Fong (75)
  3. Jatin Shah (72)
  4. Valerie Rusch (66)
  5. William Jarnagin (63)
  6. Leslie Blumgart (62)

More People

Years
  1. 2024 (13)
  2. 2023 (38)
  3. 2022 (30)
  4. 2021 (23)
  5. 2020 (52)
  6. 2019 (31)

More Years

Publications
  1. Cancer (173)
  2. Journal of Clinical Oncology (117)
  3. Annals of Surgical Oncology (93)
  4. International Journal of Radiation Oncology, Biology, Physics (63)
  5. Gynecologic Oncology (59)
  6. Annals of Surgery (58)

More Publications

Publishers
  1. Elsevier Inc. (351)
  2. Wiley Blackwell (229)
  3. Springer (204)
  4. Elsevier Science, Inc. (200)
  5. Lippincott Williams & Wilkins (149)
  6. American Society of Clinical Oncology (120)

More Publishers

Results (2078)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evaluating frailty, mortality, and complications associated with metastatic spine tumor surgery using machine learning–derived body composition analysis
    Journal Article

    Massaad, E.; Bridge, C. P.; Kiapour, A.; Fourman, M. S.; Duvall, J. B.; Connolly, I. D.; Hadzipasic, M.; Shankar, G. M.; Andriole, K. P.; Rosenthal, M.; more...
    Journal of Neurosurgery: Spine (2022)

    Fulltext@MSK | Save
  • Anterior skull base sarcomas: Report of characteristics and outcomes at a tertiary care cancer center
    Journal Article

    Long, S.; Asimakopoulos, P.; McGill, M.; Cohen, M. A.; Patel, S. G.; Shah, J. P.; Ganly, I.
    Journal of Neurological Surgery. Part B: Skull Base (2022)

    Fulltext@MSK | Save
  • CD34+ -selected hematopoietic stem cell transplant conditioned with a myeloablative regimen in patients with advanced myelofibrosis
    Journal Article

    Nawas, M. T.; Lee, J. O.; Flynn, J.; Maloy, M.; Jakubowski, A. A.; Papadopoulos, E. B.; Cho, C.; Ponce, D. M.; Sauter, C. S.; Perales, M. A.; more...
    Bone Marrow Transplantation (2022)

    Fulltext@MSK | Save
  • A clinician perspective on the treatment of chronic myeloid leukemia in the chronic phase
    Review

    García-Gutiérrez, V.; Breccia, M.; Jabbour, E.; Mauro, M.; Cortes, J. E.
    Journal of Hematology & Oncology (2022)

    Fulltext@MSK | Save
  • Replication of overall survival, progression-free survival, and overall response in chemotherapy arms of non-small cell lung cancer trials using real-world data
    Journal Article

    Ton, T. G. N.; Pal, N.; Trinh, H.; Mahrus, S.; Bretscher, M. T.; Machado, R. J. M.; Sadetsky, N.; Chaudhary, N.; Lu, M. W.; Riely, G. J.
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • CT radiomics to predict early hepatic recurrence after resection for intrahepatic cholangiocarcinoma
    Conference Paper

    Chakraborty, J.; Jolissaint, J. S.; Wang, T.; Soares, K. C.; Gonen, M.; Pak, L. M.; Boerner, T.; Do, R. K. G.; Balachandran, V. P.; D'Angelica, M. I.; more...
    SPIE (2022)

    Fulltext@MSK | Save
  • Crossing survival curves of KEYNOTE-177 illustrate the rationale behind combining immune checkpoint inhibition with chemotherapy – Authors' reply
    Correspondence

    André, T.; Diaz, L. A. Jr; Shiu, K. K.
    Lancet Oncology (2022)

    Fulltext@MSK | Save
  • Response monitoring in metastatic breast cancer: A comparison of survival times between FDG-PET/CT and CE-CT
    Journal Article

    Naghavi-Behzad, M.; Vogsen, M.; Vester, R. M.; Olsen, M. M. B.; Oltmann, H.; Braad, P. E.; Asmussen, J. T.; Gerke, O.; Vach, W.; Kidholm, K.; more...
    British Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): Final analysis of a randomised, open-label, phase 3 study
    Journal Article

    Diaz, L. A. Jr; Shiu, K. K.; Kim, T. W.; Jensen, B. V.; Jensen, L. H.; Punt, C.; Smith, D.; Garcia-Carbonero, R.; Benavides, M.; Gibbs, P.; more...
    Lancet Oncology (2022)

    Fulltext@MSK | Save
  • Listeria delivers tetanus toxoid protein to pancreatic tumors and induces cancer cell death in mice
    Journal Article

    Selvanesan, B. C.; Chandra, D.; Quispe-Tintaya, W.; Jahangir, A.; Patel, A.; Meena, K.; Da Silva, R. A. A.; Friedman, M.; Gabor, L.; Khouri, O.; more...
    Science Translational Medicine (2022)

    Fulltext@MSK | Save